Dr. Mark Kozloff, MD – Chicago, IL

  • Primary Systemic therapy in resectable pancreatic ductal adenocarcinoma using Mfolfirinox: A pilot study  

    Robert de W, Marsh MD, Mark S. Talamonti MD, Marshal S. Baker MD, Mitchell Posner MD, Kevin Roggin MD, Jeffrey Matthews MD, Daniel Catenacci MD, Mark Kozloff MD, Blasé..., Journal of Surgical Oncology, 1/16/2017
  • Phase I study of capecitabine, oxaliplatin, bevacizumab, and everolimus in advanced solid tumors  

    Rangwala F. Bendell JC, Kozlof MF, Arrowood CC, Dellinger A, Meadows J, Tourt-Uhlig S, Murphy J, Meadows KL, Starr A, Broderick S, Brady JC, Cushman SM, Morse MA, Uron..., Investigational New Drugs, 1/9/2014
  • Safety and effectiveness of bevacizumab treatment for metastatic colorectal cancer: final results from the Avastin Registry - Investigation of Effectiveness and Safety...  

    Hurwitz HI, Bekaii-Saab TS, Bendell JC, Cohn AL, Kozloff M, Roach N, Mun Y, Fish S, Flick ED, Grothey A, Clinical Oncology, 1/1/2014
  • Join now to see all
  • You Might Also Like